Ballicules.com

Mivacurium

MIVACRON

Mivacurium ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Mivacurium ballicule

What it isShort-acting non-depolarizing blocker hydrolyzed by plasma cholinesterase; brief procedures.

Why this oneIt is the only non-depolarizing agent short enough to substitute for succinylcholine in short cases.

What limits itProlonged block in pseudocholinesterase deficiency, the same trap as succinylcholine. Histamine release.

Mivacurium molecular structure (skeletal formula)
Molecular structure: Mivacurium

FDA-approved for

NO BOXED WARNINGS

Principal riskProlonged block in pseudocholinesterase deficiency

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger4 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4

Legacy pregnancy categoryC

Defining liabilityRespiratory paralysis, histamine hypotension and cholinesterase-dependent prolonged blockade

Open Mivacurium in the interactive console ↗